BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity (BRAVE)
Breast Cancer
About this trial
This is an interventional screening trial for Breast Cancer focused on measuring breast cancer, mammogram, screening, risk assessment
Eligibility Criteria
Inclusion Criteria:
- ages 25-49
Exclusion Criteria:
- personal history of breast cancer
Sites / Locations
- Vanderbilt University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Experimental
Experimental
Experimental
Intervention plus 12 months maintenance
Intervention plus 10 months maintenance
Intervention plus 8 months maintenance
Intervention plus 6 months maintenance
Intervention plus 4 months maintenance
Clinics in this group will be in the control phase for 2 months, receive the 4 month intervention, and be in the maintenance phase for 12 months.
Clinics in this group will be in the control phase for 4 months, receive the 4 month intervention, and be in the maintenance phase for 10 months.
Clinics in this group will be in the control phase for 6 months, receive the 4 month intervention, and be in the maintenance phase for 8 months.
Clinics in this group will be in the control phase for 8 months, receive the 4 month intervention, and be in the maintenance phase for 6 months.
Clinics in this group will be in the control phase for 10 months, receive the 4 month intervention, and be in the maintenance phase for 4 months.